| RS2147089236 |
STS
|
Health Risk |
Likely pathogenic |
X-linked ichthyosis with steryl-sulfatase deficiency, X-linked ichthyosis with steryl-sulfatase deficiency |
| RS2147089265 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS2147089334 |
RP2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 2, Retinitis pigmentosa 2 |
| RS2147089573 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS2147089633 |
FTSJ1
|
Health Risk |
Pathogenic |
— |
| RS2147089642 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147089995 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147090682 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS2147090694 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS2147091121 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS2147091894 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147095645 |
CASK
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental disorder, Syndromic X-linked intellectual disability Najm type |
| RS2147095810 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2147095916 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2147095950 |
CASK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147095994 |
CASK
|
Health Risk |
Likely pathogenic |
Intellectual disability, CASK-related |
| RS2147096093 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2147096217 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2147096232 |
IQSEC2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2147096420 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS2147096455 |
GLRA2
|
Health Risk |
Likely pathogenic |
See cases, Intellectual developmental disorder |
| RS2147096776 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147096963 |
IQSEC2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2147097507 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2147097839 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147099953 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS2147102426 |
IQSEC2
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147103024 |
MAOA
|
Health Risk |
Conflicting classifications of pathogenicity |
Brunner syndrome, Inborn genetic diseases |
| RS2147103761 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147104281 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147105351 |
TLK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2147106503 |
FRMPD4
|
Health Risk |
Likely pathogenic |
— |
| RS2147107556 |
MAOA
|
Health Risk |
Pathogenic |
Brunner syndrome, Brunner syndrome |
| RS2147107697 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2147108214 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147111812 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2147112134 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2147113534 |
USP9X
|
Health Risk |
Likely pathogenic |
See cases, Thyroid cancer |
| RS2147113826 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2147114173 |
ARHGEF9
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 8 |
| RS2147114191 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2147114206 |
ARHGEF9
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 8 |
| RS2147115316 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2147116755 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2147118205 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2147118758 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147118833 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147118855 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147120336 |
GSS
|
Health Risk |
Likely pathogenic |
Inherited glutathione synthetase deficiency, Inherited glutathione synthetase deficiency |
| RS2147121012 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147122044 |
PORCN
|
Health Risk |
Likely pathogenic |
— |
| RS2147122288 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147122581 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147122623 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147122655 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147122741 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147122795 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147123261 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2147123290 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2147123496 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2147123782 |
CNKSR2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2147123908 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS2147124229 |
PORCN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2147124401 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2147126983 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2147126994 |
USP9X
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2147127449 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2147128134 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147128208 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147128222 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147128300 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147128410 |
EIF2S3
|
Health Risk |
Likely pathogenic |
MEHMO syndrome, MEHMO syndrome |
| RS2147129316 |
EIF2S3
|
Health Risk |
Conflicting classifications of pathogenicity |
MEHMO syndrome, MEHMO syndrome |
| RS2147130188 |
PORCN
|
Health Risk |
Likely pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2147131515 |
EIF2S3
|
Health Risk |
Pathogenic |
MEHMO syndrome, MEHMO syndrome |
| RS2147131609 |
PORCN
|
Health Risk |
Pathogenic |
— |
| RS2147131642 |
PORCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2147132223 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147132235 |
CDKL5
|
Health Risk |
Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147132253 |
CDKL5
|
Health Risk |
Likely pathogenic |
— |
| RS2147132274 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147136759 |
RBM10
|
Health Risk |
Pathogenic |
TARP syndrome, TARP syndrome |
| RS2147138207 |
CASK
|
Health Risk |
Pathogenic |
X-linked syndromic intellectual disability, X-linked syndromic intellectual disability |
| RS2147138406 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS2147139052 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147139089 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147139114 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2147139131 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147139133 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2147139522 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147139532 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS2147139605 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147139669 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147139674 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147139684 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147139830 |
PORCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2147140951 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2147141032 |
NHS
|
Health Risk |
Pathogenic |
— |
| RS2147142586 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS2147142599 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |